Document is current
Any future updates will be listed below
-
Authors
Pike, Steven C.
Wiencke, John K.
Zhang, Ze
Molinaro, Annette M.
Hansen, Helen M.
Koestler, Devin C.
Christensen, Brock C.
Kelsey, Karl T.
Salas, Lucas A. https://orcid.org/0000-0002-2279-4097
-
Funding
Funding for this research was provided by:
National Institutes of Health, National Institute of General Medical Sciences (P20 GM104416, P30 GM149408)
National Institutes of Health, National Cancer Institute (P30 CA023108, R01 CA207360, P50 CA097257, P30 CA168524, P20 GM130423, R01 CA216265, R01 CA253976)
Johnson and Johnson Innovation (18‐90‐52‐MICH)
- License Information
-
More Information
Article History
Received: 16 July 2024
Accepted: 12 October 2024
First Online: 28 October 2024
Declarations
:
: J.K.W., K.T.K., L.A.S., and B.C.C. are co-founders of Cellintec, which had no role in this research. B.C.C. is an advisor to Guardant Health, which had no role in this research. A U.S. Provisional Patent Application entitled, “Glioma Immune Microenvironment Composition Calculator (GIMiCC) a method of estimating the proportions of eighteen key cell types from glioma DNA methylation microarray data”, was filed on January 29, 2024, by Dartmouth College for the <i>GIMiCC</i> deconvolution libraries invention included in this manuscript. Inventors: Salas LA, Christensen BC, Zhang Z, Pike SC, KT Kelsey, JK Wiencke, DC Koestler, AM Molinaro. The remaining authors declare no competing interests.
